Biden and Sanders Announce Significant Reductions in Drug Prices

In a landmark move, President Biden and Senator Bernie Sanders have successfully negotiated lower prices for essential medications, marking a major victory against Big Pharma.

President Biden and Senator Bernie Sanders showcased their efforts to lower drug costs, including capping insulin prices at $35 for Medicare recipients.
The collaboration has led to one inhaler manufacturer dropping patents, while three others plan to cap inhaler costs at $35 a month for many patients.
Biden aims to extend these cost-capping measures to all Americans, with a shared goal of limiting annual health care costs to $2,000.
The initiative is part of Biden's broader election-year focus on reducing health care expenses, despite polls indicating low voter awareness.
The effort has sparked criticism from the Republican Study Committee, which proposes budget cuts that could undermine opioid crisis programs.